{"cluster": 62, "subcluster": 12, "abstract_summ": "Here, we report that average SARS CoV-2 Mpro is 1900% more sensitive than SARS CoV-1 Mpro in transmitting tiny structural changes across the whole protein through long-range interactions.However, few residues contribute significantly to the protein stability and thus can be considered as key anchoring residues for Mpro inhibitor design.Here we report sequence analysis, structure predictions, and molecular modeling for seventy-nine Mpro variants, constituting all clinically observed mutations in this protein as of April 29, 2020.Here we report that as average SARS CoV-2 Mpro is 1900% more sensitive than SARS CoV-1 Mpro in transmitting tiny structural changes across the whole protein through long-range interactions.In spite of a high level of sequence similarity, the active sites in both proteins show major differences in both shape and size indicating that repurposing SARS drugs for COVID-19 may be futile.", "title_summ": "Impact of emerging mutations on the dynamic properties the SARS-CoV-2 main protease: an in silico investigationGlycoinformatics approach for identifying target positions to inhibit initial binding of SARS-CoV-2 S1 protein to the host cellTopological Analysis of SARS CoV-2 Main ProteaseStructural and Evolutionary Analysis Indicate that the SARS-CoV-2 Mpro is an Inconvenient Target for Small-Molecule Inhibitors DesignSequence characterization and molecular modeling of clinically relevant variants of the SARS-CoV-2 main proteaseStructural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor DesignTopological analysis of SARS CoV-2 main protease.", "title_abstract_phrases": "Here we report sequence analysis, structure predictions, and molecular modeling for seventy-nine Mpro variants, constituting all clinically observed mutations in this protein as of April 29, 2020.Here, we report that average SARS CoV-2 Mpro is 1900% more sensitive than SARS CoV-1 Mpro in transmitting tiny structural changes across the whole protein through long-range interactions.Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor DesignThe novel coronavirus whose outbreak took place in December 2019 continues to spread at a rapid rate worldwide.These findings, based on a simplified representation of the protein as a residue network, may help in designing potent inhibitors of SARS CoV-2 Mpro.These findings, based on a simplified representation of the protein as a residue network, may help in designing potent inhibitors of SARS CoV-2 Mpro."}